{"gene":"CA2","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":1972,"finding":"The crystal structure of human carbonic anhydrase II (CA II, then called carbonic anhydrase C) was determined, revealing a zinc ion in the active site coordinated by three histidine residues and establishing the enzyme's overall fold.","method":"X-ray crystallography","journal":"Nature: New biology","confidence":"High","confidence_rationale":"Tier 1 — original crystal structure, foundational and widely replicated","pmids":["4621826"],"is_preprint":false},{"year":1988,"finding":"Refined 2.0 Å crystal structure of human CA II showed the zinc ion coordinated tetrahedrally to three histidyl residues (His94, His96, His119) and one water molecule; Thr-199 donates a proton to Glu-106 and acts as a hydrogen-bond acceptor in the active site, clarifying hydrogen-bond donor-acceptor relations critical for catalysis.","method":"Constrained and restrained structure-factor least-squares X-ray crystallographic refinement at 2.0 Å","journal":"Proteins","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with detailed active-site analysis, foundational paper","pmids":["3151019"],"is_preprint":false},{"year":1988,"finding":"X-ray crystallographic studies of CA II inhibitor complexes showed: (1) sulfonamide inhibitors (AMS, acetazolamide) bind via the sulfonamide nitrogen to the zinc, retaining tetrahedral zinc geometry; (2) at high pH, thiocyanate forms a pentacoordinated zinc complex with both SCN- and a water molecule bound to zinc plus three histidines; (3) mercury binds at His-64 and Cys-206. These structures defined three possible zinc coordination geometries and informed the catalytic and inhibition mechanisms.","method":"X-ray crystallography of inhibitor-bound CA II complexes at 1.9–3.1 Å resolution","journal":"Proteins","confidence":"High","confidence_rationale":"Tier 1 — multiple crystal structures with distinct inhibitors, rigorous structural analysis","pmids":["3151020"],"is_preprint":false},{"year":1985,"finding":"Virtual absence of carbonic anhydrase II (CAII) enzymatic activity (CO2 hydratase and esterase) and immunoprecipitable CAII protein was demonstrated in erythrocyte hemolysates from 18 patients in 11 families with the autosomal recessive syndrome of osteopetrosis, renal tubular acidosis, and cerebral calcification, establishing CAII deficiency as the biochemical basis of this syndrome.","method":"High-performance liquid chromatography, enzyme activity assays (CO2 hydratase, esterase), immunoprecipitation of erythrocyte hemolysates","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical methods across 11 unrelated families, strong evidence","pmids":["3925334"],"is_preprint":false},{"year":1992,"finding":"v-erbA oncogene acts as a constitutive transcriptional repressor of the carbonic anhydrase II (CAII) gene in erythroblasts; reintroduction of CAII via retroviral vectors into v-erbA-transformed erythroblasts restored normal pH/ion tolerance of the cells, demonstrating that CAII expression is required for erythroblast pH homeostasis but does not reverse the v-erbA-induced differentiation block.","method":"Retroviral gene transfer of CAII into transformed erythroblasts, cell growth assays across pH/ionic-strength gradients","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 — genetic rescue experiment with defined phenotypic readout in a single cellular system","pmids":["1354613"],"is_preprint":false},{"year":1995,"finding":"Comprehensive review establishing that CA II is cytoplasmic, the most catalytically active carbonic anhydrase isozyme (highest kcat/Km for CO2 hydration), and that structural/kinetic studies of recombinant wild-type and mutant CA II have defined the structural requirements for catalysis, including the zinc-bound hydroxide mechanism.","method":"Review synthesizing kinetic studies of recombinant natural and mutant CAs, inhibitor studies, and CA-deficient animal/human data","journal":"Annual review of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — synthesis of multiple in vitro reconstitution and mutagenesis studies across many labs","pmids":["7574487"],"is_preprint":false},{"year":1998,"finding":"CA II binds directly to the 33-residue carboxyl-terminal (Ct) region of the erythrocyte Cl-/HCO3- exchanger band 3 (AE1) with K1/2 ~20–100 nM; the interaction was demonstrated by co-immunoprecipitation from ghost membranes, co-solubilization, solid-phase binding assays with GST-Ct fusion proteins, and affinity chromatography showing 1:1 stoichiometry. Clustering of band 3 in membranes caused co-clustering of CAII, indicating an in situ physical association.","method":"Co-immunoprecipitation, co-solubilization, solid-phase binding assay, affinity chromatography, immunofluorescence clustering","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal binding assays with quantitative Kd and stoichiometry determination, confirmed in situ","pmids":["9774471"],"is_preprint":false},{"year":2000,"finding":"The CA II binding site on AE1 was mapped to residues 887–890 (D887ADD) within the carboxyl-terminal 33-residue region; mutation of D887ADD to AAAA or NANN abolished CAII binding, while mutation to D887ANE (the homologous AE2 sequence) retained binding, identifying acidic residues at this motif as critical for CA II tethering to the anion exchanger.","method":"Peptide competition assays, truncation and point mutant GST-fusion protein binding assays (microtiter plate binding assay) with immobilized CAII","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic mutagenesis with quantitative binding assay, defines precise binding determinants","pmids":["10820026"],"is_preprint":false},{"year":2001,"finding":"CA II forms a 'transport metabolon' with AE1 (and AE2, AE3 cardiac isoforms): inhibition of endogenous CA with acetazolamide reduced AE1-mediated Cl-/HCO3- exchange by 50–60% in HEK293 cells; AE1 mutants unable to bind CAII retained only ~10% of wild-type transport activity; displacement of endogenous CAII by a functionally inactive dominant-negative mutant (V143Y) inhibited AE1 activity by ~61%, demonstrating that direct CAII binding to AE1 potentiates anion transport activity.","method":"Intracellular pH-based anion exchange assay in transfected HEK293 cells, dominant-negative CAII co-transfection, CA inhibitor (acetazolamide) treatment, AE1 CAII-binding mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — functional assay with multiple orthogonal approaches (inhibitor, dominant-negative, binding mutants), replicated across AE isoforms","pmids":["11606574"],"is_preprint":false},{"year":2002,"finding":"CA II binds to the C-terminal region of the Na+/H+ exchanger NHE1 (demonstrated by microtiter plate binding assay, affinity blotting, and co-immunoprecipitation from CHO cells); CAII binding enhances NHE1 H+ transport rate ~2-fold; acetazolamide (CA inhibitor) and dominant-negative CAII both reduced NHE1 activity; phosphorylation of the NHE1 C-terminus greatly increased CAII binding, suggesting phosphorylation-dependent modulation of CAII–NHE1 interaction.","method":"Microtiter plate binding assay, affinity blotting, co-immunoprecipitation from CHO cells, intracellular pH-based transport assays, dominant-negative CAII, phosphorylation studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (binding, co-IP, functional assay, mutagenesis/phosphorylation), consistent results","pmids":["12138085"],"is_preprint":false},{"year":2003,"finding":"A novel frameshift mutation in CA2 was identified in a consanguineous kindred with osteopetrosis and distal renal tubular acidosis (dRTA), confirming loss-of-function of CAII as causative; in a second kindred with identical clinical phenotype, CAII levels were normal, revealing that co-inheritance of mutations in TCIRG1 (osteoclast H+-ATPase subunit a) and ATP6V1B1 (kidney H+-ATPase B1 subunit) can phenocopy CAII deficiency, mechanistically separating the bone and kidney components.","method":"Molecular genetic analysis (sequencing, homozygosity mapping), CAII protein quantification, gene exclusion studies","journal":"Journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 — genetic dissection with molecular confirmation; defines CA2 pathway in bone/kidney acid-base regulation","pmids":["12566520"],"is_preprint":false},{"year":2004,"finding":"Celecoxib and valdecoxib (COX-2-selective NSAIDs bearing arylsulfonamide groups) inhibit CA II with nanomolar affinity; X-ray crystal structure of the celecoxib–CA II complex showed the sulfonamide nitrogen coordinates the catalytic zinc ion, while the trifluoromethylphenyl ring occupies the hydrophobic half of the active site, demonstrating an unexpected cross-reactivity that lowers intraocular pressure in glaucomatous rabbits.","method":"Enzyme kinetics (CO2 hydratase assay), X-ray crystallography of CA II–celecoxib complex, in vivo intraocular pressure measurement","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation (kinetics + in vivo), strong mechanistic insight","pmids":["14736236"],"is_preprint":false},{"year":2005,"finding":"Coumarins are suicide inhibitors of CA II: X-ray crystal structure of the CA II–coumarin complex revealed that the coumarin is hydrolyzed in the active site to a cis-2-hydroxy-cinnamic acid derivative, which plugs the entrance to the active site through interactions with Phe131, Asn67, and Glu238 without coordinating the zinc ion—representing a novel, non-zinc-mediated inhibition mechanism distinct from classical sulfonamide inhibitors.","method":"X-ray crystallography of CA II–coumarin adduct, enzyme kinetics (inhibition of all 13 mammalian CA isoforms), time-dependent inhibition assays","journal":"Journal of the American Chemical Society","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with kinetic characterization across isoforms, identifies a new class of inhibition mechanism","pmids":["19206230"],"is_preprint":false},{"year":2005,"finding":"Zonisamide (antiepileptic drug) is a potent time-dependent inhibitor of CA II (Ki = 35.2 nM after 1-h incubation, vs. apparent 10.3 µM at 15 min); X-ray crystal structure at 1.70 Å showed the sulfonamide moiety coordinates the zinc ion via classic interactions with Thr199 and Glu106, while the benzisoxazole ring makes extensive van der Waals interactions with hydrophobic residues (Gln92, Val121, Phe131, Leu198, Thr200, Pro202).","method":"Enzyme kinetics (time-dependent CO2 hydrase inhibition assay), X-ray crystallography at 1.70 Å","journal":"Bioorganic & medicinal chemistry letters","confidence":"High","confidence_rationale":"Tier 1 — crystal structure combined with kinetic characterization revealing time-dependence","pmids":["15837316"],"is_preprint":false},{"year":2007,"finding":"Ultra-high resolution (1.05 Å) X-ray crystal structure of unliganded CA II combined with molecular dynamics (MD) simulations revealed: (1) His64 adopts a dual conformation (inward/outward, ~80% inward); (2) a specific solvent network including water molecule W2 is positioned for proton relay between Zn-bound water and His64; (3) comparison of crystallographic anisotropic B-factors with MD root-mean-square fluctuations showed excellent agreement, supporting a proton-transfer mechanism via the solvent bridge to His64 as rate-limiting step.","method":"X-ray crystallography at 1.05 Å resolution (Rcryst 12.0%, Rfree 15.1%), molecular dynamics simulation","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — atomic-resolution crystal structure plus MD simulation with cross-validation, defines proton-transfer mechanism","pmids":["17319692"],"is_preprint":false},{"year":2009,"finding":"The dissociation constant of ethoxzolamide binding to human CA II was determined to be ~2 nM by displacement isothermal titration calorimetry (ITC) and thermal shift assay (TSA); ligand binding stabilized CA II by >10°C in Tm, and two separate melting transitions (ligand-free and ligand-bound fractions) were observed, validating combined ITC/TSA as a method for measuring tight CA II–inhibitor interactions.","method":"Displacement isothermal titration calorimetry (ITC), thermal shift assay (TSA), analysis of melting temperature dependence on protein and ligand concentrations","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 — rigorous biophysical measurement with two orthogonal methods; single study","pmids":["19582223"],"is_preprint":false},{"year":2011,"finding":"Simple inorganic anions (including azide, cyanate, cyanide, thiocyanate, bisulfite, nitrate, nitrite, iodide, and others) inhibit CA II through diverse mechanisms: some coordinate the zinc directly (e.g., thiocyanate, azide forming pentacoordinate zinc), while others bind in the active site without direct zinc coordination, providing structural and mechanistic insight into enzyme inhibition and the catalytic zinc environment.","method":"Enzyme kinetics (CO2 hydrase inhibition assays), review of X-ray crystallographic structures of anion-CA II complexes","journal":"Journal of inorganic biochemistry","confidence":"High","confidence_rationale":"Tier 1 — synthesis of multiple crystal structures and kinetic studies across labs","pmids":["22192857"],"is_preprint":false},{"year":1984,"finding":"CA II is expressed in Müller glial cells of the mature chicken and mouse retina; during embryonic development CA II is first expressed broadly in all retinoblasts, then becomes restricted to Müller cells (and transiently to amacrine neurons), suggesting CA II has a role in glial support functions; comparative analysis across vertebrates revealed species-specific CA II distribution in horizontal cells and amacrine neurons.","method":"Immunohistochemistry with polyclonal and monoclonal antibodies to CA II in vertebrate retinas across developmental stages","journal":"Annals of the New York Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 3 — direct localization by immunohistochemistry; no direct functional consequence tested","pmids":["6430181"],"is_preprint":false},{"year":1992,"finding":"In CA II-deficient mice, membrane-associated carbonic anhydrase (CA) activity was preserved along the nephron (proximal tubule apical and basolateral membranes, thin limb, thick limb, distal tubule basolateral membranes), while cytoplasmic CA II staining was absent, demonstrating that membrane-bound CA isoforms (distinct from CA II) mediate transepithelial ion transport in renal tubules; in collecting duct, Type A intercalated cells showed apical membrane CA activity and Type B showed basolateral, consistent with their respective directions of H+ secretion.","method":"Immunocytochemistry (CA II) and cobalt-phosphate CA histochemistry in CA II-deficient and control mouse kidneys","journal":"The journal of histochemistry and cytochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — comparison of CA II-null vs. control mice with histochemistry provides direct functional localization insight","pmids":["1431055"],"is_preprint":false},{"year":1994,"finding":"In CA II-deficient mouse eyes, intense membrane-associated CA activity was preserved at apical and basolateral membranes of ciliary (pigmented and non-pigmented) epithelium, corneal endothelium, retinal pigment epithelium, Müller cells, lens epithelium, and choroidal/retinal capillary endothelium, demonstrating that membrane CA isoforms (not CA II) underlie transepithelial fluid and ion transport in the eye; inhibition of basolateral membrane CA of non-pigmented ciliary epithelium is proposed to explain aqueous humor reduction by CA inhibitors.","method":"Cobalt-phosphate CA histochemistry in CA II-deficient and normal mouse eyes","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — CA II-null vs. control comparison reveals membrane CA localization without cytoplasmic CA II interference","pmids":["8163345"],"is_preprint":false},{"year":2019,"finding":"CA II (CAII) is upregulated in tumor endothelial cells (TECs) compared to normal endothelial cells both in vitro and in vivo; CAII knockdown decreased TEC survival specifically under lactic acidosis conditions; VEGF-A/VEGFR signaling induced CAII expression in normal endothelial cells; pharmacological CA inhibition with acetazolamide reduced lung metastasis in xenograft models, establishing CAII as a pH-regulatory survival factor in the tumor microenvironment.","method":"siRNA knockdown, Western blot, ELISA, cell proliferation (MTS assay), VEGF treatment, xenograft mouse models with acetazolamide treatment, immunohistochemistry","journal":"Cell communication and signaling : CCS","confidence":"Medium","confidence_rationale":"Tier 2 — knockdown with defined phenotypic readout plus in vivo confirmation; single lab study","pmids":["31847904"],"is_preprint":false}],"current_model":"Human CA2 (carbonic anhydrase II) is a cytoplasmic zinc metalloenzyme that catalyzes reversible CO2 hydration via a zinc-bound hydroxide mechanism, with the rate-limiting step being intramolecular proton transfer between the zinc-bound water and His64 through an ordered active-site solvent network; it forms transport metabolons by directly binding (via acidic motif D887ADD) to the C-terminal cytoplasmic tails of the Cl-/HCO3- exchanger AE1 and the Na+/H+ exchanger NHE1 to potentiate their transport activities, and its loss causes the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification, while sulfonamides, coumarins, and diverse anions inhibit the enzyme by zinc-coordinating or non-zinc active-site mechanisms defined by high-resolution crystal structures."},"narrative":{"teleology":[{"year":1972,"claim":"Determination of the first crystal structure of human CA II revealed the zinc-containing active site and overall protein fold, establishing the structural framework for all subsequent mechanistic studies.","evidence":"X-ray crystallography of human carbonic anhydrase C","pmids":["4621826"],"confidence":"High","gaps":["Resolution insufficient to define hydrogen-bond network or solvent structure","Active-site mechanism and catalytic cycle not yet elucidated"]},{"year":1985,"claim":"Demonstration that CA II enzymatic activity and protein are virtually absent in patients with osteopetrosis, renal tubular acidosis, and cerebral calcification established CA2 loss-of-function as the molecular basis of this autosomal recessive syndrome, linking the enzyme to bone resorption and renal acid-base homeostasis.","evidence":"HPLC, CO2 hydratase/esterase activity assays, and immunoprecipitation of erythrocyte hemolysates from 18 patients in 11 families","pmids":["3925334"],"confidence":"High","gaps":["Whether the bone and kidney phenotypes arise from a single common mechanism or separate tissue-specific functions was unclear","Specific causative mutations not yet identified at the DNA level in most families"]},{"year":1988,"claim":"High-resolution refinement of the CA II structure resolved the tetrahedral zinc coordination (His94, His96, His119, water) and the Thr199–Glu106 hydrogen-bond relay, defining the catalytic geometry, while inhibitor co-crystal structures established that sulfonamides coordinate zinc via the sulfonamide nitrogen and that alternative zinc coordination geometries are possible.","evidence":"X-ray crystallography at 2.0 Å (apo) and 1.9–3.1 Å (inhibitor complexes)","pmids":["3151019","3151020"],"confidence":"High","gaps":["Proton-transfer pathway and rate-limiting step not yet defined","Solvent network in the active site not resolved at this resolution"]},{"year":1995,"claim":"Systematic kinetic and mutagenesis studies consolidated the zinc-bound hydroxide mechanism and identified CA II as the most catalytically efficient CA isozyme, framing subsequent work on the proton shuttle.","evidence":"Review synthesizing recombinant wild-type and mutant CA kinetics, inhibitor studies, and CA-deficient animal/human data","pmids":["7574487"],"confidence":"High","gaps":["Atomic-resolution definition of the proton-transfer solvent bridge remained outstanding","Role of His64 conformational dynamics not directly observed"]},{"year":1998,"claim":"Discovery that CA II binds directly to the C-terminal cytoplasmic tail of the Cl⁻/HCO₃⁻ exchanger AE1 with nanomolar affinity introduced the concept that CA II participates in membrane transport by physical association with ion transporters.","evidence":"Co-immunoprecipitation from ghost membranes, solid-phase binding assays, affinity chromatography, and immunofluorescence clustering","pmids":["9774471"],"confidence":"High","gaps":["Functional consequence of the CA II–AE1 interaction on transport activity not yet tested","Binding determinants on AE1 not yet mapped"]},{"year":2000,"claim":"Mapping the CA II binding site on AE1 to the acidic motif D887ADD, with mutagenesis showing that acidic residues are essential, defined the molecular determinants of the CA II–transporter interaction.","evidence":"Peptide competition and point-mutant GST-fusion binding assays with immobilized CA II","pmids":["10820026"],"confidence":"High","gaps":["No structure of the CA II–AE1 peptide complex","Reciprocal mapping of the binding surface on CA II not performed"]},{"year":2001,"claim":"Functional demonstration that CA II binding to AE1 potentiates Cl⁻/HCO₃⁻ exchange activity—using CA inhibitors, binding-deficient AE1 mutants, and dominant-negative CA II—established the 'transport metabolon' concept wherein substrate channeling between enzyme and transporter accelerates transmembrane bicarbonate flux.","evidence":"Intracellular pH-based anion exchange assay in transfected HEK293 cells with multiple perturbations","pmids":["11606574"],"confidence":"High","gaps":["Whether physical tethering alone or catalytic activity at the membrane interface drives the enhancement was not fully resolved","In vivo physiological confirmation in tissue lacking"]},{"year":2002,"claim":"Extension of the metabolon concept to NHE1 showed that CA II also binds NHE1's C-terminal region and enhances Na⁺/H⁺ exchange, with phosphorylation of NHE1 greatly increasing CA II binding, revealing a regulated partnership.","evidence":"Microtiter plate binding, affinity blotting, co-IP from CHO cells, pH-based transport assays, dominant-negative CA II, phosphorylation studies","pmids":["12138085"],"confidence":"High","gaps":["Kinase(s) responsible for the phosphorylation-dependent regulation not identified","Structural basis of phospho-dependent enhancement unknown"]},{"year":2003,"claim":"Identification of a novel CA2 frameshift mutation in a family with osteopetrosis plus renal tubular acidosis, alongside the finding that co-inheritance of TCIRG1 and ATP6V1B1 mutations can phenocopy CA II deficiency, mechanistically separated the bone and kidney acid-secretion pathways downstream of CA II.","evidence":"Molecular genetic sequencing, homozygosity mapping, and CA II protein quantification in two kindreds","pmids":["12566520"],"confidence":"Medium","gaps":["Small number of families limits generalizability","Relative contribution of CA II to osteoclast versus renal intercalated cell H⁺ secretion not quantified"]},{"year":2007,"claim":"An ultra-high-resolution (1.05 Å) crystal structure combined with molecular dynamics defined the His64 dual conformation and the ordered solvent network mediating proton transfer from zinc-bound water to His64, establishing the rate-limiting proton shuttle as the mechanistic basis for CA II's extraordinary catalytic turnover.","evidence":"X-ray crystallography at 1.05 Å with anisotropic B-factor analysis cross-validated by MD simulation","pmids":["17319692"],"confidence":"High","gaps":["Direct experimental observation of proton transfer dynamics (e.g., neutron diffraction, time-resolved methods) not yet achieved at that time","Contribution of individual water molecules in the relay not individually tested by mutagenesis"]},{"year":2009,"claim":"Discovery that coumarins inhibit CA II through a suicide mechanism—hydrolysis to cis-2-hydroxy-cinnamic acid that occludes the active-site entrance without zinc coordination—revealed a fundamentally distinct inhibition mode from classical sulfonamides, expanding the pharmacological toolkit.","evidence":"X-ray crystallography of the CA II–coumarin adduct and enzyme kinetics across 13 mammalian CA isoforms","pmids":["19206230"],"confidence":"High","gaps":["Selectivity profile of coumarins among CA isoforms not fully optimized","In vivo efficacy data for coumarin-class inhibitors limited"]},{"year":2019,"claim":"Demonstration that CA II is upregulated in tumor endothelial cells via VEGF-A/VEGFR signaling and that it promotes survival under lactic acidosis, with acetazolamide reducing metastasis in vivo, extended CA II's physiological role to pH homeostasis in the tumor microenvironment.","evidence":"siRNA knockdown, VEGF treatment, xenograft mouse models with acetazolamide, immunohistochemistry","pmids":["31847904"],"confidence":"Medium","gaps":["Single-lab study; independent replication needed","Whether the anti-metastatic effect is CA II-specific or reflects pan-CA inhibition by acetazolamide is unresolved","Molecular mechanism linking CA II to endothelial cell survival under acidosis not defined"]},{"year":null,"claim":"Key unresolved questions include the structural basis of the CA II–transporter metabolon (no co-crystal structure of CA II bound to AE1 or NHE1 cytoplasmic domains), the identity of kinases regulating the CA II–NHE1 interaction, direct visualization of proton-transfer dynamics in real time, and whether CA II has non-catalytic scaffolding functions independent of its enzymatic activity.","evidence":"","pmids":[],"confidence":"Low","gaps":["No co-crystal structure of the CA II–transporter complex","Kinases phosphorylating NHE1 to enhance CA II binding unidentified","In vivo tissue-specific functions beyond erythrocytes and kidney not systematically characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,5,14]},{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[1,5,14]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,18]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,5,14]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[6,7,8,9]}],"complexes":[],"partners":["SLC4A1","SLC9A1"],"other_free_text":[]},"mechanistic_narrative":"CA2 encodes carbonic anhydrase II, the most catalytically efficient cytoplasmic zinc metalloenzyme among carbonic anhydrase isozymes, catalyzing reversible hydration of CO2 to bicarbonate via a zinc-bound hydroxide mechanism in which intramolecular proton transfer from the zinc-water to His64 through an ordered solvent network constitutes the rate-limiting step [PMID:7574487, PMID:17319692]. The active site zinc is tetrahedrally coordinated by His94, His96, His119, and a water/hydroxide molecule, with Thr199 and Glu106 forming a hydrogen-bond network essential for catalysis [PMID:3151019]. CA2 directly binds the cytoplasmic tails of the Cl⁻/HCO₃⁻ exchanger AE1 (via the D887ADD motif) and the Na⁺/H⁺ exchanger NHE1, forming transport metabolons that potentiate bicarbonate and proton flux across membranes [PMID:9774471, PMID:11606574, PMID:12138085]. Loss-of-function mutations in CA2 cause an autosomal recessive syndrome of osteopetrosis, renal tubular acidosis, and cerebral calcification [PMID:3925334, PMID:12566520]."},"prefetch_data":{"uniprot":{"accession":"P00918","full_name":"Carbonic anhydrase 2","aliases":["Carbonate dehydratase II","Carbonic anhydrase C","CAC","Carbonic anhydrase II","CA-II","Cyanamide hydratase CA2"],"length_aa":260,"mass_kda":29.2,"function":"Catalyzes the reversible hydration of carbon dioxide (PubMed:11327835, PubMed:11802772, PubMed:11831900, PubMed:12056894, PubMed:12171926, PubMed:1336460, PubMed:14736236, PubMed:15300855, PubMed:15453828, PubMed:15667203, PubMed:15865431, PubMed:16106378, PubMed:16214338, PubMed:16290146, PubMed:16686544, PubMed:16759856, PubMed:16807956, PubMed:17127057, PubMed:17251017, PubMed:17314045, PubMed:17330962, PubMed:17346964, PubMed:17540563, PubMed:17588751, PubMed:17705204, PubMed:18024029, PubMed:18162396, PubMed:18266323, PubMed:18374572, PubMed:18481843, PubMed:18618712, PubMed:18640037, PubMed:18942852, PubMed:1909891, PubMed:1910042, PubMed:19170619, PubMed:19186056, PubMed:19206230, PubMed:19520834, PubMed:19778001, PubMed:7761440, PubMed:7901850, PubMed:8218160, PubMed:8262987, PubMed:8399159, PubMed:8451242, PubMed:8485129, PubMed:8639494, PubMed:9265618, PubMed:9398308). Can also hydrate cyanamide to urea (PubMed:10550681, PubMed:11015219). Stimulates the chloride-bicarbonate exchange activity of SLC26A6 (PubMed:15990874). Essential for bone resorption and osteoclast differentiation (PubMed:15300855). Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption","subcellular_location":"Cytoplasm; Cell membrane","url":"https://www.uniprot.org/uniprotkb/P00918/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CA2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CA2","total_profiled":1310},"omim":[{"mim_id":"621356","title":"SH3 AND CYSTEINE-RICH DOMAINS 2; STAC2","url":"https://www.omim.org/entry/621356"},{"mim_id":"621250","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 118; DEE118","url":"https://www.omim.org/entry/621250"},{"mim_id":"621025","title":"RAB3A-INTERACTING PROTEIN-LIKE 1; RAB3IL1","url":"https://www.omim.org/entry/621025"},{"mim_id":"621008","title":"MYOSIN LIGHT CHAIN KINASE FAMILY, MEMBER 4; MYLK4","url":"https://www.omim.org/entry/621008"},{"mim_id":"620787","title":"T-CELL ACTIVATION INHIBITOR, MITOCHONDRIAL; TCAIM","url":"https://www.omim.org/entry/620787"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"choroid plexus","ntpm":944.3},{"tissue":"intestine","ntpm":644.2},{"tissue":"stomach 1","ntpm":1046.9}],"url":"https://www.proteinatlas.org/search/CA2"},"hgnc":{"alias_symbol":["Car2","CA-II","CAII"],"prev_symbol":[]},"alphafold":{"accession":"P00918","domains":[{"cath_id":"3.10.200.10","chopping":"12-256","consensus_level":"high","plddt":98.0742,"start":12,"end":256}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P00918","model_url":"https://alphafold.ebi.ac.uk/files/AF-P00918-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P00918-F1-predicted_aligned_error_v6.png","plddt_mean":97.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CA2","jax_strain_url":"https://www.jax.org/strain/search?query=CA2"},"sequence":{"accession":"P00918","fasta_url":"https://rest.uniprot.org/uniprotkb/P00918.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P00918/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P00918"}},"corpus_meta":[{"pmid":"16005298","id":"PMC_16005298","title":"STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx.","date":"2005","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16005298","citation_count":1801,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8628289","id":"PMC_8628289","title":"Calcineurin inhibits VCX1-dependent H+/Ca2+ exchange and induces Ca2+ ATPases in Saccharomyces cerevisiae.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8628289","citation_count":379,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10740296","id":"PMC_10740296","title":"CDPKs - a kinase for every Ca2+ signal?","date":"2000","source":"Trends in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/10740296","citation_count":348,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7919018","id":"PMC_7919018","title":"Effects of rapid buffers on Ca2+ diffusion and Ca2+ oscillations.","date":"1994","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/7919018","citation_count":305,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17716241","id":"PMC_17716241","title":"Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17716241","citation_count":294,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1970637","id":"PMC_1970637","title":"Glutamate receptors activate Ca2+ mobilization and Ca2+ influx into astrocytes.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1970637","citation_count":237,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3158824","id":"PMC_3158824","title":"Ca2+-dependent and Ca2+-independent phagocytosis in human neutrophils.","date":"1985","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/3158824","citation_count":202,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8361348","id":"PMC_8361348","title":"Regulation by Ca2+ in the Yersinia low-Ca2+ response.","date":"1993","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8361348","citation_count":177,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2750887","id":"PMC_2750887","title":"Caffeine-induced Ca2+ release activates Ca2+ extrusion via Na+-Ca2+ exchanger in cardiac myocytes.","date":"1989","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2750887","citation_count":155,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18984909","id":"PMC_18984909","title":"NAADP: a universal Ca2+ trigger.","date":"2008","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/18984909","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8702966","id":"PMC_8702966","title":"Arachidonic acid activates the noncapacitative entry of Ca2+ during [Ca2+]i oscillations.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8702966","citation_count":139,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9838027","id":"PMC_9838027","title":"Inositol trisphosphate receptors: Ca2+-modulated intracellular Ca2+ channels.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9838027","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16415789","id":"PMC_16415789","title":"Ca2+ shuttling between endoplasmic reticulum and mitochondria underlying Ca2+ oscillations.","date":"2006","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/16415789","citation_count":128,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8436297","id":"PMC_8436297","title":"CAR2, a prestalk cAMP receptor required for normal tip formation and late development of Dictyostelium discoideum.","date":"1993","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8436297","citation_count":125,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1699445","id":"PMC_1699445","title":"Interaction of ruthenium red with Ca2(+)-binding proteins.","date":"1990","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1699445","citation_count":125,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2387861","id":"PMC_2387861","title":"Ca2(+)-induced conformational change and aggregation of chromogranin A.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2387861","citation_count":122,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17158339","id":"PMC_17158339","title":"Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.","date":"2006","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/17158339","citation_count":121,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8947828","id":"PMC_8947828","title":"Ca2+ signaling and intracellular Ca2+ binding proteins.","date":"1996","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8947828","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17351009","id":"PMC_17351009","title":"Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites.","date":"2007","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17351009","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14660663","id":"PMC_14660663","title":"Molecular determinants of Na+/Ca2+ exchange (NCX1) inhibition by SEA0400.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14660663","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14617355","id":"PMC_14617355","title":"Function of caveolae in Ca2+ entry and Ca2+-dependent signal transduction.","date":"2003","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/14617355","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15659591","id":"PMC_15659591","title":"Endogenous Ca2+ buffer concentration and Ca2+ microdomains in hippocampal neurons.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15659591","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12869611","id":"PMC_12869611","title":"Epithelial Ca2+ entry channels: transcellular Ca2+ transport and beyond.","date":"2003","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12869611","citation_count":94,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8386529","id":"PMC_8386529","title":"Colocalization of active KCa channels and Ca2+ channels within Ca2+ domains in helix neurons.","date":"1993","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/8386529","citation_count":93,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2457581","id":"PMC_2457581","title":"Two Ca2+-dependent ATPases in rat liver plasma membrane. The previously purified (Ca2+-Mg2+)-ATPase is not a Ca2+-pump but an ecto-ATPase.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2457581","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22223119","id":"PMC_22223119","title":"Ca2+-dependent modulation of voltage-gated Ca2+ channels.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22223119","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7696462","id":"PMC_7696462","title":"Properties of intracellular Ca2+ waves generated by a model based on Ca(2+)-induced Ca2+ release.","date":"1994","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/7696462","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12586823","id":"PMC_12586823","title":"Mitochondrial Ca2+ uptake requires sustained Ca2+ release from the endoplasmic reticulum.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12586823","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8745210","id":"PMC_8745210","title":"Stimulation of the Na+/Ca2+ exchanger by phenylephrine, angiotensin II and endothelin 1.","date":"1996","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/8745210","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19243429","id":"PMC_19243429","title":"Compartmentalized signalling: Ca2+ compartments, microdomains and the many facets of Ca2+ signalling.","date":"2009","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/19243429","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25591931","id":"PMC_25591931","title":"Evolution of acidic Ca²⁺ stores and their resident Ca²⁺-permeable channels.","date":"2014","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/25591931","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12566520","id":"PMC_12566520","title":"A phenocopy of CAII deficiency: a novel genetic explanation for inherited infantile osteopetrosis with distal renal tubular acidosis.","date":"2003","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12566520","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3002822","id":"PMC_3002822","title":"Role of Ca2+ and Ca2+-activated protease in myoblast fusion.","date":"1986","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/3002822","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16990699","id":"PMC_16990699","title":"Topics on the Na+/Ca2+ exchanger: pharmacological characterization of Na+/Ca2+ exchanger inhibitors.","date":"2006","source":"Journal of pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16990699","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1324019","id":"PMC_1324019","title":"Two roles of Ca2+ in agonist stimulated Ca2+ oscillations.","date":"1992","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/1324019","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2174508","id":"PMC_2174508","title":"Mode of action of alpha-latrotoxin: role of divalent cations in Ca2(+)-dependent and Ca2(+)-independent effects mediated by the toxin.","date":"1990","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/2174508","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2301565","id":"PMC_2301565","title":"Ca2(+)-induced Ca2+ release as examined by photolysis of caged Ca2+ in single ventricular myocytes.","date":"1990","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2301565","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15820398","id":"PMC_15820398","title":"Presynaptic Ca2+ dynamics, Ca2+ buffers and synaptic efficacy.","date":"2005","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/15820398","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10856121","id":"PMC_10856121","title":"Effects of the immunosuppressant FK506 on intracellular Ca2+ release and Ca2+ accumulation mechanisms.","date":"2000","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10856121","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2912132","id":"PMC_2912132","title":"Relationship between cytosolic free Ca2+ and Na+-Ca2+ exchange in aortic muscle cells.","date":"1989","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2912132","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8485319","id":"PMC_8485319","title":"The surface cyclic AMP receptors, cAR1, cAR2, and cAR3, promote Ca2+ influx in Dictyostelium discoideum by a G alpha 2-independent mechanism.","date":"1993","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/8485319","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19211671","id":"PMC_19211671","title":"Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2.","date":"2009","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19211671","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15184369","id":"PMC_15184369","title":"Ca2+ dependence of the Ca2+-selective TRPV6 channel.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15184369","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1354613","id":"PMC_1354613","title":"Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.","date":"1992","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1354613","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22822058","id":"PMC_22822058","title":"Ca2+-dependent transcriptional control of Ca2+ homeostasis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22822058","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31847904","id":"PMC_31847904","title":"Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment.","date":"2019","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/31847904","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8769822","id":"PMC_8769822","title":"Inhibition of Na+ and Ca2+ reabsorption by P2u purinoceptors requires PKC but not Ca2+ signaling.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8769822","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6430181","id":"PMC_6430181","title":"Variable CA II compartmentalization in vertebrate retina.","date":"1984","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/6430181","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11668069","id":"PMC_11668069","title":"Overexpression of Na+/Ca2+ exchanger alters contractility and SR Ca2+ content in adult rat myocytes.","date":"2001","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11668069","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15611234","id":"PMC_15611234","title":"Modulation of Ca2+ signaling by Na+/Ca2+ exchangers in mast cells.","date":"2005","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15611234","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10222236","id":"PMC_10222236","title":"Ca2+/calmodulin-dependent phosphorylation of the Ca2+-ATPase, uncoupled from phospholamban, stimulates Ca2+-pumping in native cardiac sarcoplasmic reticulum.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10222236","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15653756","id":"PMC_15653756","title":"Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes.","date":"2005","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15653756","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19582223","id":"PMC_19582223","title":"Measurement of nanomolar dissociation constants by titration calorimetry and thermal shift assay - radicicol binding to Hsp90 and ethoxzolamide binding to CAII.","date":"2009","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/19582223","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9688923","id":"PMC_9688923","title":"Thyroid control of sarcolemmal Na+/Ca2+ exchanger and SR Ca2+-ATPase in developing rat heart.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9688923","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2158297","id":"PMC_2158297","title":"Alterations in heart sarcolemmal Ca2(+)-ATPase and Ca2(+)-binding activities due to oxygen free radicals.","date":"1990","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/2158297","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9883283","id":"PMC_9883283","title":"Ca2+ entry in CHO cells, after Ca2+ stores depletion, is mediated by arachidonic acid.","date":"1998","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/9883283","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15557343","id":"PMC_15557343","title":"Calcineurin inhibits Na+/Ca2+ exchange in phenylephrine-treated hypertrophic cardiomyocytes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15557343","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8853396","id":"PMC_8853396","title":"Protein kinase C mediates Ca2(+)-induced cardioadaptation to ischemia-reperfusion injury.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8853396","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16099501","id":"PMC_16099501","title":"Ca2+ signalling in cardiogenesis.","date":"2005","source":"Cell calcium","url":"https://pubmed.ncbi.nlm.nih.gov/16099501","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15499375","id":"PMC_15499375","title":"Bax affects intracellular Ca2+ stores and induces Ca2+ wave propagation.","date":"2004","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/15499375","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11752507","id":"PMC_11752507","title":"HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjögren's syndrome.","date":"2001","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11752507","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12363284","id":"PMC_12363284","title":"Ca2+-dependent and Ca2+-independent regulation of smooth muscle contraction.","date":"2002","source":"Journal of muscle research and cell motility","url":"https://pubmed.ncbi.nlm.nih.gov/12363284","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16751288","id":"PMC_16751288","title":"Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange.","date":"2006","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16751288","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19864608","id":"PMC_19864608","title":"Ca2+ waves initiate antigen-stimulated Ca2+ responses in mast cells.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19864608","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2191871","id":"PMC_2191871","title":"Cyclic AMP- and Ca2(+)-dependent protein kinases in Plasmodium falciparum.","date":"1990","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/2191871","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8997179","id":"PMC_8997179","title":"Na+/Ca2+ exchange currents and SR Ca2+ contents in postinfarction myocytes.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8997179","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9672237","id":"PMC_9672237","title":"Na+/Ca2+ exchange and cellular Ca2+ homeostasis.","date":"1998","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/9672237","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17367507","id":"PMC_17367507","title":"Ca2+-pumps and Na2+-Ca2+-exchangers in coronary artery endothelium versus smooth muscle.","date":"2007","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17367507","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2142157","id":"PMC_2142157","title":"Monomeric state and Ca2+ transport by sarcoplasmic reticulum Ca2(+)-ATPase, reconstituted with an excess of phospholipid.","date":"1990","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2142157","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8163345","id":"PMC_8163345","title":"Membrane-associated CA activity in the eye of the CA II-deficient mouse.","date":"1994","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/8163345","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3099842","id":"PMC_3099842","title":"Modulation of Na+-Ca2+ exchange and Ca2+ permeability in cardiac sarcolemmal vesicles by doxylstearic acids.","date":"1987","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/3099842","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10191496","id":"PMC_10191496","title":"The Ca2+ pumps and the Na+/Ca2+ exchangers.","date":"1998","source":"Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10191496","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8631493","id":"PMC_8631493","title":"The cAMP receptor subtype cAR2 is restricted to a subset of prestalk cells during Dictyostelium development and displays unexpected DIF-1 responsiveness.","date":"1996","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8631493","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16641927","id":"PMC_16641927","title":"Hypertension, Na+/Ca2+ exchanger, and Na+, K+-ATPase.","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16641927","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17959231","id":"PMC_17959231","title":"The role of the Na+/Ca2+ exchangers in Ca2+ dynamics in ventricular myocytes.","date":"2007","source":"Progress in biophysics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17959231","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"411523","id":"PMC_411523","title":"Non-cooperative Ca(II) removal and terbium(III) substitution in carp muscle calcium binding parvalbumin.","date":"1977","source":"Bioinorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/411523","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20307742","id":"PMC_20307742","title":"Ca2+ extrusion via Na+-Ca2+ exchangers in rat odontoblasts.","date":"2010","source":"Journal of endodontics","url":"https://pubmed.ncbi.nlm.nih.gov/20307742","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25979335","id":"PMC_25979335","title":"Endothelial Angiogenesis and Barrier Function in Response to Thrombin Require Ca2+ Influx through the Na+/Ca2+ Exchanger.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25979335","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1850620","id":"PMC_1850620","title":"19F NMR studies of the D-galactose chemosensory receptor. 2. Ca(II) binding yields a local structural change.","date":"1991","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1850620","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26689452","id":"PMC_26689452","title":"Cell-Permeable Esterase-Activated Ca(II)-Sensitive MRI Contrast Agent.","date":"2016","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26689452","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11274218","id":"PMC_11274218","title":"Split Na+-Ca2+ exchangers. Implications for function and expression.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11274218","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18690036","id":"PMC_18690036","title":"Reversed Na+/Ca2+ exchange contributes to Ca2+ influx and respiratory burst in microglia.","date":"2007","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18690036","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1695896","id":"PMC_1695896","title":"lcrR, a low-Ca2(+)-response locus with dual Ca2(+)-dependent functions in Yersinia pestis.","date":"1990","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/1695896","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17446450","id":"PMC_17446450","title":"Regulation of cardiac Na+/Ca2+ exchanger by phospholemman.","date":"2007","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17446450","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8797115","id":"PMC_8797115","title":"Ca2+ oscillations and intercellular Ca2+ waves in ATP-stimulated articular chondrocytes.","date":"1996","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/8797115","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9252464","id":"PMC_9252464","title":"Na+/Ca2+ exchanger in Drosophila: cloning, expression, and transport differences.","date":"1997","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9252464","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8386484","id":"PMC_8386484","title":"Depletion and refilling of intracellular Ca2+ stores induce oscillations of Ca2+ current.","date":"1993","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8386484","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8229815","id":"PMC_8229815","title":"Ca(2+)-dependent inactivation of Ca2+ current in Aplysia neurons: kinetic studies using photolabile Ca2+ chelators.","date":"1993","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8229815","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17194715","id":"PMC_17194715","title":"CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristics.","date":"2006","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/17194715","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8601325","id":"PMC_8601325","title":"Measurement of human erythrocyte CAI and CAII in adult, newborn, and fetal blood.","date":"1996","source":"Clinical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8601325","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2440312","id":"PMC_2440312","title":"Pituitary Ca2+ channels: blockade by conventional and novel Ca2+ antagonists.","date":"1987","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/2440312","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10809695","id":"PMC_10809695","title":"In Saccharomyces cerevisiae, expression of arginine catabolic genes CAR1 and CAR2 in response to exogenous nitrogen availability is mediated by the Ume6 (CargRI)-Sin3 (CargRII)-Rpd3 (CargRIII) complex.","date":"2000","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/10809695","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1782213","id":"PMC_1782213","title":"Ca(2+)-induced Ca2+ release amplifies the Ca2+ response elicited by inositol trisphosphate in macrophages.","date":"1991","source":"Cell regulation","url":"https://pubmed.ncbi.nlm.nih.gov/1782213","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23159627","id":"PMC_23159627","title":"Ca²⁺ influx-dependent refilling of intracellular Ca²⁺ stores determines the frequency of Ca²⁺ oscillations in fertilized mouse eggs.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23159627","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1431055","id":"PMC_1431055","title":"Membrane-associated carbonic anhydrase activity in the kidney of CA II-deficient mice.","date":"1992","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/1431055","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12151011","id":"PMC_12151011","title":"Sustained Ca2+-induced Ca2+-release underlies the post-glutamate lethal Ca2+ plateau in older cultured hippocampal neurons.","date":"2002","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12151011","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26849136","id":"PMC_26849136","title":"By Regulating Mitochondrial Ca2+-Uptake UCP2 Modulates Intracellular Ca2+.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26849136","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7730413","id":"PMC_7730413","title":"Ca2+ waves in PC12 neurites: a bidirectional, receptor-oriented form of Ca2+ signaling.","date":"1995","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7730413","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1850414","id":"PMC_1850414","title":"Ca2(+)-enhanced phosphorylation of a chimeric protein kinase involved with bacterial signal transduction.","date":"1991","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1850414","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20226808","id":"PMC_20226808","title":"Ca2+ signaling and STIM1.","date":"2010","source":"Progress in biophysics and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20226808","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7574487","id":"PMC_7574487","title":"Human carbonic anhydrases and carbonic anhydrase deficiencies.","date":"1995","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7574487","citation_count":667,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14718574","id":"PMC_14718574","title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14718574","citation_count":658,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18976975","id":"PMC_18976975","title":"Genome-scale RNAi screen for host factors required for HIV replication.","date":"2008","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/18976975","citation_count":627,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3151019","id":"PMC_3151019","title":"Refined structure of human carbonic anhydrase II at 2.0 A resolution.","date":"1988","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/3151019","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19206230","id":"PMC_19206230","title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors.","date":"2009","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/19206230","citation_count":425,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"4621826","id":"PMC_4621826","title":"Crystal structure of human carbonic anhydrase C.","date":"1972","source":"Nature: New biology","url":"https://pubmed.ncbi.nlm.nih.gov/4621826","citation_count":358,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14736236","id":"PMC_14736236","title":"Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.","date":"2004","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14736236","citation_count":338,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11606574","id":"PMC_11606574","title":"A transport metabolon. Functional interaction of carbonic anhydrase II and chloride/bicarbonate exchangers.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11606574","citation_count":296,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32812023","id":"PMC_32812023","title":"Phosphorylated tau interactome in the human Alzheimer's disease brain.","date":"2020","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32812023","citation_count":290,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3925334","id":"PMC_3925334","title":"Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification.","date":"1985","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/3925334","citation_count":253,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25940091","id":"PMC_25940091","title":"La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1).","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25940091","citation_count":213,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9774471","id":"PMC_9774471","title":"Carbonic anhydrase II binds to the carboxyl terminus of human band 3, the erythrocyte C1-/HCO3- exchanger.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9774471","citation_count":199,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23720494","id":"PMC_23720494","title":"Genome-wide association study identifies loci affecting blood copper, selenium and zinc.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23720494","citation_count":197,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32203420","id":"PMC_32203420","title":"Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203420","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22192857","id":"PMC_22192857","title":"(In)organic anions as carbonic anhydrase inhibitors.","date":"2011","source":"Journal of inorganic biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22192857","citation_count":169,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12138085","id":"PMC_12138085","title":"Carbonic anhydrase II binds to and enhances activity of the Na+/H+ exchanger.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12138085","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15837316","id":"PMC_15837316","title":"Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.","date":"2005","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/15837316","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3151020","id":"PMC_3151020","title":"Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH.","date":"1988","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/3151020","citation_count":152,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10820026","id":"PMC_10820026","title":"Identification of the carbonic anhydrase II binding site in the Cl(-)/HCO(3)(-) anion exchanger AE1.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10820026","citation_count":144,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17319692","id":"PMC_17319692","title":"Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism.","date":"2007","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17319692","citation_count":143,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49234,"output_tokens":1875,"usd":0.087914},"stage2":{"model":"claude-opus-4-6","input_tokens":4802,"output_tokens":1883,"usd":0.106628},"total_usd":0.525248,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":62851,"output_tokens":6457,"usd":0.142704},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9407,"output_tokens":3132,"usd":0.188002}},"stage1_raw":"Looking at the abstracts, I need to identify which papers are about CA2 (carbonic anhydrase II, the human/mammalian enzyme) versus other genes that share similar symbols or are unrelated.\n\nThe relevant CA2 papers are:\n- PMID 12566520: CA2 mutations causing osteopetrosis with RTA (CAII deficiency)\n- PMID 6430181: CA II compartmentalization in vertebrate retina\n- PMID 19582223: Ethoxzolamide binding to hCAII (ITC/TSA binding assay)\n- PMID 1354613: v-erbA repression of CAII in erythroblasts, functional rescue\n- PMID 8163345: Membrane-associated CA activity in CA II-deficient mouse eye\n- PMID 1431055: Membrane-associated CA in kidney of CA II-deficient mice\n- PMID 8601325: CA I and CA II measurement in erythrocytes\n\nMost other papers describe Ca2+ signaling, Na+/Ca2+ exchangers, CAR1/CAR2 cAMP receptors in Dictyostelium, yeast CAR1/CAR2 arginine catabolism genes, or human CAR nuclear receptors — all unrelated to the carbonic anhydrase II gene CA2.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"Reintroduction of CAII into v-erbA-transformed erythroblasts abrogated the v-erbA-induced tolerance to pH and ionic strength variation, demonstrating that CAII is required for normal pH/ion homeostasis in erythroid cells and that its transcriptional repression by v-erbA directly contributes to a component of the leukemic phenotype.\",\n      \"method\": \"Retrovirus-mediated re-expression of CA2 in v-erbA-transformed erythroblasts with functional readout (pH/ion tolerance rescue); differentiation block assessed separately\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean rescue experiment with specific phenotypic readout in a defined cellular context, single lab\",\n      \"pmids\": [\"1354613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"CA II protein is compartmentalized in a cell-type-specific and developmentally regulated manner in vertebrate retina: in mature chicken retina it is restricted to Müller glial cells, whereas during embryogenesis it is transiently expressed broadly in retinoblasts and later in a subset of amacrine neurons; in mouse, high CA II levels persist in certain amacrine neurons at maturity.\",\n      \"method\": \"Polyclonal and monoclonal antibody immunohistochemistry across multiple vertebrate species and developmental stages\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by immunohistochemistry across species and developmental stages, single lab but systematic comparative analysis\",\n      \"pmids\": [\"6430181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Loss-of-function mutations in CA2 (including a novel frameshift) cause the autosomal recessive syndrome of osteopetrosis combined with mixed proximal/distal renal tubular acidosis (Guibaud-Vainsel syndrome), establishing CAII as essential for normal osteoclast bone resorption and renal tubular acid-base handling.\",\n      \"method\": \"Molecular genetic analysis of consanguineous kindreds; sequencing of CA2; CAII protein level measurement; genetic exclusion of CA2 defects in a phenocopy kindred\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined molecular and clinical phenotype, but single study without in vitro enzymatic reconstitution\",\n      \"pmids\": [\"12566520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"In CA II-deficient mice, membrane-associated carbonic anhydrase activity is preserved in the ciliary epithelium, corneal endothelium, retinal pigment epithelium, Müller cells, lens, and capillary endothelium of the eye, demonstrating that membrane-bound CA isoforms (not CAII) are responsible for ocular fluid/ion transport and that CAII is the predominant cytoplasmic isozyme.\",\n      \"method\": \"Cobalt-phosphate histochemical CA assay in CA II-deficient versus normal mice eyes\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional localization using genetic null model with direct enzyme histochemistry\",\n      \"pmids\": [\"8163345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"In kidneys of CA II-deficient mice, cytoplasmic CA II is absent from proximal tubule, thick limb of Henle, and collecting duct principal/intercalated cells, while membrane-associated CA activity at apical and basolateral membranes of proximal tubule, thin limb, thick limb, and intercalated cells is preserved, revealing CAII as the dominant cytoplasmic renal carbonic anhydrase and distinguishing its role from that of membrane-bound isoforms.\",\n      \"method\": \"Immunocytochemistry (anti-CAII) and cobalt-phosphate histochemical CA assay in CA II-deficient versus control mouse kidneys\",\n      \"journal\": \"The journal of histochemistry and cytochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization using genetic null model with both immunochemical and enzymatic histochemical methods\",\n      \"pmids\": [\"1431055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Human CA II (hCAII) binds the sulfonamide inhibitor ethoxzolamide with a dissociation constant of ~2 nM, as measured by displacement isothermal titration calorimetry and thermal shift assay; ligand binding stabilizes hCAII by >10°C, and free and ligand-bound protein fractions melt independently.\",\n      \"method\": \"Displacement isothermal titration calorimetry (ITC) and thermal shift assay (TSA) with purified human CAII protein\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assay with purified protein using two orthogonal biophysical methods in single study\",\n      \"pmids\": [\"19582223\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Carbonic anhydrase II (CA2) is a cytoplasmic zinc metalloenzyme that catalyzes the reversible hydration of CO2; it is essential for acid-base regulation in osteoclasts and renal tubular cells (loss-of-function causes osteopetrosis with renal tubular acidosis), functions in erythroid pH/ion homeostasis, is the dominant cytoplasmic CA isoform in kidney and retina (distinguishable from membrane-bound isoforms using CA II-null mice), and binds sulfonamide inhibitors with low nanomolar affinity.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEEP papers.\n\n**Classification:**\n\nThe gene CA2 = Human Carbonic Anhydrase II (CAII), a zinc metalloenzyme catalyzing CO2 ↔ HCO3- interconversion.\n\nMost papers in the main corpus (papers 1-100) are about Ca2+ (calcium ion) signaling — completely different from CA2/CAII. These are EXCLUDE (alias collision: \"Ca2+\" vs \"CA2\").\n\nExceptions in main corpus:\n- Paper [32]: mentions CAII deficiency, CA2 gene, osteopetrosis → KEEP\n- Paper [44]: mentions carbonic anhydrase II (CAII) repression by v-erbA → KEEP\n- Paper [46]: CAII in tumor endothelial cells → KEEP (expression/functional)\n- Paper [48]: CA II distribution in retina → KEEP\n- Paper [53]: hCAII binding with ethoxzolamide → KEEP\n- Paper [70]: membrane-associated CA activity in CA II-deficient mouse eye → KEEP\n- Paper [90]: erythrocyte CAI and CAII measurement → KEEP (expression only, no mechanism)\n- Paper [95]: CA II in kidney of CA II-deficient mice → KEEP\n\nAdditional curated papers - classify:\n- [1] protein interaction network (Y2H) → KEEP (CA2 interactions identified)\n- [2] cDNA sequences → EXCLUDE (no mechanism)\n- [3] DUB interactome → KEEP if CA2 mentioned mechanistically — it's a global screen, CA2 not specifically studied → EXCLUDE\n- [4] cDNA sequences → EXCLUDE\n- [5] Human carbonic anhydrases review → KEEP\n- [6] plasma proteome → EXCLUDE\n- [7] GO annotations → EXCLUDE\n- [8] HIV RNAi screen → EXCLUDE\n- [9] urinary exosomes proteomics → EXCLUDE\n- [10] MGC cDNA → EXCLUDE\n- [11] Crystal structure of human CA II at 2.0 Å → KEEP\n- [12] Coumarins as CA II inhibitors, X-ray structure → KEEP\n- [13] chromosome segregation proteomics → EXCLUDE\n- [14] alternative promoters → EXCLUDE\n- [15] Crystal structure of human carbonic anhydrase C (= CA II) → KEEP\n- [16] Celecoxib binds CA II, crystal structure → KEEP\n- [17] CRL network proteomics → EXCLUDE\n- [18] CA II binds AE1, transport metabolon → KEEP\n- [19] phospho-tau interactome → EXCLUDE\n- [20] CA II deficiency in osteopetrosis families → KEEP\n- [21] LARP1/mTORC1 → EXCLUDE\n- [22] CA II binds carboxyl terminus of band 3 → KEEP\n- [23] GWAS for blood metals, CA locus for Zn → marginally relevant, no CA2 mechanism → EXCLUDE\n- [24] RhoGEF/RhoGAP → EXCLUDE\n- [25] Inorganic anion inhibitors of CA → KEEP\n- [26] CA II binds NHE1, enhances activity → KEEP\n- [27] Zonisamide inhibits CA II, X-ray structure → KEEP\n- [28] Inhibitor binding sites in CA II, X-ray → KEEP\n- [29] CA II binding site in AE1 → KEEP\n- [30] CA II proton transfer mechanism, crystal + MD → KEEP\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1972,\n      \"finding\": \"The crystal structure of human carbonic anhydrase II (CA II, then called carbonic anhydrase C) was determined, revealing a zinc ion in the active site coordinated by three histidine residues and establishing the enzyme's overall fold.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature: New biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original crystal structure, foundational and widely replicated\",\n      \"pmids\": [\"4621826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Refined 2.0 Å crystal structure of human CA II showed the zinc ion coordinated tetrahedrally to three histidyl residues (His94, His96, His119) and one water molecule; Thr-199 donates a proton to Glu-106 and acts as a hydrogen-bond acceptor in the active site, clarifying hydrogen-bond donor-acceptor relations critical for catalysis.\",\n      \"method\": \"Constrained and restrained structure-factor least-squares X-ray crystallographic refinement at 2.0 Å\",\n      \"journal\": \"Proteins\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with detailed active-site analysis, foundational paper\",\n      \"pmids\": [\"3151019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"X-ray crystallographic studies of CA II inhibitor complexes showed: (1) sulfonamide inhibitors (AMS, acetazolamide) bind via the sulfonamide nitrogen to the zinc, retaining tetrahedral zinc geometry; (2) at high pH, thiocyanate forms a pentacoordinated zinc complex with both SCN- and a water molecule bound to zinc plus three histidines; (3) mercury binds at His-64 and Cys-206. These structures defined three possible zinc coordination geometries and informed the catalytic and inhibition mechanisms.\",\n      \"method\": \"X-ray crystallography of inhibitor-bound CA II complexes at 1.9–3.1 Å resolution\",\n      \"journal\": \"Proteins\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple crystal structures with distinct inhibitors, rigorous structural analysis\",\n      \"pmids\": [\"3151020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1985,\n      \"finding\": \"Virtual absence of carbonic anhydrase II (CAII) enzymatic activity (CO2 hydratase and esterase) and immunoprecipitable CAII protein was demonstrated in erythrocyte hemolysates from 18 patients in 11 families with the autosomal recessive syndrome of osteopetrosis, renal tubular acidosis, and cerebral calcification, establishing CAII deficiency as the biochemical basis of this syndrome.\",\n      \"method\": \"High-performance liquid chromatography, enzyme activity assays (CO2 hydratase, esterase), immunoprecipitation of erythrocyte hemolysates\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical methods across 11 unrelated families, strong evidence\",\n      \"pmids\": [\"3925334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"v-erbA oncogene acts as a constitutive transcriptional repressor of the carbonic anhydrase II (CAII) gene in erythroblasts; reintroduction of CAII via retroviral vectors into v-erbA-transformed erythroblasts restored normal pH/ion tolerance of the cells, demonstrating that CAII expression is required for erythroblast pH homeostasis but does not reverse the v-erbA-induced differentiation block.\",\n      \"method\": \"Retroviral gene transfer of CAII into transformed erythroblasts, cell growth assays across pH/ionic-strength gradients\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue experiment with defined phenotypic readout in a single cellular system\",\n      \"pmids\": [\"1354613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Comprehensive review establishing that CA II is cytoplasmic, the most catalytically active carbonic anhydrase isozyme (highest kcat/Km for CO2 hydration), and that structural/kinetic studies of recombinant wild-type and mutant CA II have defined the structural requirements for catalysis, including the zinc-bound hydroxide mechanism.\",\n      \"method\": \"Review synthesizing kinetic studies of recombinant natural and mutant CAs, inhibitor studies, and CA-deficient animal/human data\",\n      \"journal\": \"Annual review of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — synthesis of multiple in vitro reconstitution and mutagenesis studies across many labs\",\n      \"pmids\": [\"7574487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CA II binds directly to the 33-residue carboxyl-terminal (Ct) region of the erythrocyte Cl-/HCO3- exchanger band 3 (AE1) with K1/2 ~20–100 nM; the interaction was demonstrated by co-immunoprecipitation from ghost membranes, co-solubilization, solid-phase binding assays with GST-Ct fusion proteins, and affinity chromatography showing 1:1 stoichiometry. Clustering of band 3 in membranes caused co-clustering of CAII, indicating an in situ physical association.\",\n      \"method\": \"Co-immunoprecipitation, co-solubilization, solid-phase binding assay, affinity chromatography, immunofluorescence clustering\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal binding assays with quantitative Kd and stoichiometry determination, confirmed in situ\",\n      \"pmids\": [\"9774471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The CA II binding site on AE1 was mapped to residues 887–890 (D887ADD) within the carboxyl-terminal 33-residue region; mutation of D887ADD to AAAA or NANN abolished CAII binding, while mutation to D887ANE (the homologous AE2 sequence) retained binding, identifying acidic residues at this motif as critical for CA II tethering to the anion exchanger.\",\n      \"method\": \"Peptide competition assays, truncation and point mutant GST-fusion protein binding assays (microtiter plate binding assay) with immobilized CAII\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis with quantitative binding assay, defines precise binding determinants\",\n      \"pmids\": [\"10820026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CA II forms a 'transport metabolon' with AE1 (and AE2, AE3 cardiac isoforms): inhibition of endogenous CA with acetazolamide reduced AE1-mediated Cl-/HCO3- exchange by 50–60% in HEK293 cells; AE1 mutants unable to bind CAII retained only ~10% of wild-type transport activity; displacement of endogenous CAII by a functionally inactive dominant-negative mutant (V143Y) inhibited AE1 activity by ~61%, demonstrating that direct CAII binding to AE1 potentiates anion transport activity.\",\n      \"method\": \"Intracellular pH-based anion exchange assay in transfected HEK293 cells, dominant-negative CAII co-transfection, CA inhibitor (acetazolamide) treatment, AE1 CAII-binding mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — functional assay with multiple orthogonal approaches (inhibitor, dominant-negative, binding mutants), replicated across AE isoforms\",\n      \"pmids\": [\"11606574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CA II binds to the C-terminal region of the Na+/H+ exchanger NHE1 (demonstrated by microtiter plate binding assay, affinity blotting, and co-immunoprecipitation from CHO cells); CAII binding enhances NHE1 H+ transport rate ~2-fold; acetazolamide (CA inhibitor) and dominant-negative CAII both reduced NHE1 activity; phosphorylation of the NHE1 C-terminus greatly increased CAII binding, suggesting phosphorylation-dependent modulation of CAII–NHE1 interaction.\",\n      \"method\": \"Microtiter plate binding assay, affinity blotting, co-immunoprecipitation from CHO cells, intracellular pH-based transport assays, dominant-negative CAII, phosphorylation studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (binding, co-IP, functional assay, mutagenesis/phosphorylation), consistent results\",\n      \"pmids\": [\"12138085\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A novel frameshift mutation in CA2 was identified in a consanguineous kindred with osteopetrosis and distal renal tubular acidosis (dRTA), confirming loss-of-function of CAII as causative; in a second kindred with identical clinical phenotype, CAII levels were normal, revealing that co-inheritance of mutations in TCIRG1 (osteoclast H+-ATPase subunit a) and ATP6V1B1 (kidney H+-ATPase B1 subunit) can phenocopy CAII deficiency, mechanistically separating the bone and kidney components.\",\n      \"method\": \"Molecular genetic analysis (sequencing, homozygosity mapping), CAII protein quantification, gene exclusion studies\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic dissection with molecular confirmation; defines CA2 pathway in bone/kidney acid-base regulation\",\n      \"pmids\": [\"12566520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Celecoxib and valdecoxib (COX-2-selective NSAIDs bearing arylsulfonamide groups) inhibit CA II with nanomolar affinity; X-ray crystal structure of the celecoxib–CA II complex showed the sulfonamide nitrogen coordinates the catalytic zinc ion, while the trifluoromethylphenyl ring occupies the hydrophobic half of the active site, demonstrating an unexpected cross-reactivity that lowers intraocular pressure in glaucomatous rabbits.\",\n      \"method\": \"Enzyme kinetics (CO2 hydratase assay), X-ray crystallography of CA II–celecoxib complex, in vivo intraocular pressure measurement\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation (kinetics + in vivo), strong mechanistic insight\",\n      \"pmids\": [\"14736236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Coumarins are suicide inhibitors of CA II: X-ray crystal structure of the CA II–coumarin complex revealed that the coumarin is hydrolyzed in the active site to a cis-2-hydroxy-cinnamic acid derivative, which plugs the entrance to the active site through interactions with Phe131, Asn67, and Glu238 without coordinating the zinc ion—representing a novel, non-zinc-mediated inhibition mechanism distinct from classical sulfonamide inhibitors.\",\n      \"method\": \"X-ray crystallography of CA II–coumarin adduct, enzyme kinetics (inhibition of all 13 mammalian CA isoforms), time-dependent inhibition assays\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with kinetic characterization across isoforms, identifies a new class of inhibition mechanism\",\n      \"pmids\": [\"19206230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Zonisamide (antiepileptic drug) is a potent time-dependent inhibitor of CA II (Ki = 35.2 nM after 1-h incubation, vs. apparent 10.3 µM at 15 min); X-ray crystal structure at 1.70 Å showed the sulfonamide moiety coordinates the zinc ion via classic interactions with Thr199 and Glu106, while the benzisoxazole ring makes extensive van der Waals interactions with hydrophobic residues (Gln92, Val121, Phe131, Leu198, Thr200, Pro202).\",\n      \"method\": \"Enzyme kinetics (time-dependent CO2 hydrase inhibition assay), X-ray crystallography at 1.70 Å\",\n      \"journal\": \"Bioorganic & medicinal chemistry letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure combined with kinetic characterization revealing time-dependence\",\n      \"pmids\": [\"15837316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Ultra-high resolution (1.05 Å) X-ray crystal structure of unliganded CA II combined with molecular dynamics (MD) simulations revealed: (1) His64 adopts a dual conformation (inward/outward, ~80% inward); (2) a specific solvent network including water molecule W2 is positioned for proton relay between Zn-bound water and His64; (3) comparison of crystallographic anisotropic B-factors with MD root-mean-square fluctuations showed excellent agreement, supporting a proton-transfer mechanism via the solvent bridge to His64 as rate-limiting step.\",\n      \"method\": \"X-ray crystallography at 1.05 Å resolution (Rcryst 12.0%, Rfree 15.1%), molecular dynamics simulation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic-resolution crystal structure plus MD simulation with cross-validation, defines proton-transfer mechanism\",\n      \"pmids\": [\"17319692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The dissociation constant of ethoxzolamide binding to human CA II was determined to be ~2 nM by displacement isothermal titration calorimetry (ITC) and thermal shift assay (TSA); ligand binding stabilized CA II by >10°C in Tm, and two separate melting transitions (ligand-free and ligand-bound fractions) were observed, validating combined ITC/TSA as a method for measuring tight CA II–inhibitor interactions.\",\n      \"method\": \"Displacement isothermal titration calorimetry (ITC), thermal shift assay (TSA), analysis of melting temperature dependence on protein and ligand concentrations\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — rigorous biophysical measurement with two orthogonal methods; single study\",\n      \"pmids\": [\"19582223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Simple inorganic anions (including azide, cyanate, cyanide, thiocyanate, bisulfite, nitrate, nitrite, iodide, and others) inhibit CA II through diverse mechanisms: some coordinate the zinc directly (e.g., thiocyanate, azide forming pentacoordinate zinc), while others bind in the active site without direct zinc coordination, providing structural and mechanistic insight into enzyme inhibition and the catalytic zinc environment.\",\n      \"method\": \"Enzyme kinetics (CO2 hydrase inhibition assays), review of X-ray crystallographic structures of anion-CA II complexes\",\n      \"journal\": \"Journal of inorganic biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — synthesis of multiple crystal structures and kinetic studies across labs\",\n      \"pmids\": [\"22192857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"CA II is expressed in Müller glial cells of the mature chicken and mouse retina; during embryonic development CA II is first expressed broadly in all retinoblasts, then becomes restricted to Müller cells (and transiently to amacrine neurons), suggesting CA II has a role in glial support functions; comparative analysis across vertebrates revealed species-specific CA II distribution in horizontal cells and amacrine neurons.\",\n      \"method\": \"Immunohistochemistry with polyclonal and monoclonal antibodies to CA II in vertebrate retinas across developmental stages\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct localization by immunohistochemistry; no direct functional consequence tested\",\n      \"pmids\": [\"6430181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"In CA II-deficient mice, membrane-associated carbonic anhydrase (CA) activity was preserved along the nephron (proximal tubule apical and basolateral membranes, thin limb, thick limb, distal tubule basolateral membranes), while cytoplasmic CA II staining was absent, demonstrating that membrane-bound CA isoforms (distinct from CA II) mediate transepithelial ion transport in renal tubules; in collecting duct, Type A intercalated cells showed apical membrane CA activity and Type B showed basolateral, consistent with their respective directions of H+ secretion.\",\n      \"method\": \"Immunocytochemistry (CA II) and cobalt-phosphate CA histochemistry in CA II-deficient and control mouse kidneys\",\n      \"journal\": \"The journal of histochemistry and cytochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — comparison of CA II-null vs. control mice with histochemistry provides direct functional localization insight\",\n      \"pmids\": [\"1431055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"In CA II-deficient mouse eyes, intense membrane-associated CA activity was preserved at apical and basolateral membranes of ciliary (pigmented and non-pigmented) epithelium, corneal endothelium, retinal pigment epithelium, Müller cells, lens epithelium, and choroidal/retinal capillary endothelium, demonstrating that membrane CA isoforms (not CA II) underlie transepithelial fluid and ion transport in the eye; inhibition of basolateral membrane CA of non-pigmented ciliary epithelium is proposed to explain aqueous humor reduction by CA inhibitors.\",\n      \"method\": \"Cobalt-phosphate CA histochemistry in CA II-deficient and normal mouse eyes\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CA II-null vs. control comparison reveals membrane CA localization without cytoplasmic CA II interference\",\n      \"pmids\": [\"8163345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CA II (CAII) is upregulated in tumor endothelial cells (TECs) compared to normal endothelial cells both in vitro and in vivo; CAII knockdown decreased TEC survival specifically under lactic acidosis conditions; VEGF-A/VEGFR signaling induced CAII expression in normal endothelial cells; pharmacological CA inhibition with acetazolamide reduced lung metastasis in xenograft models, establishing CAII as a pH-regulatory survival factor in the tumor microenvironment.\",\n      \"method\": \"siRNA knockdown, Western blot, ELISA, cell proliferation (MTS assay), VEGF treatment, xenograft mouse models with acetazolamide treatment, immunohistochemistry\",\n      \"journal\": \"Cell communication and signaling : CCS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knockdown with defined phenotypic readout plus in vivo confirmation; single lab study\",\n      \"pmids\": [\"31847904\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human CA2 (carbonic anhydrase II) is a cytoplasmic zinc metalloenzyme that catalyzes reversible CO2 hydration via a zinc-bound hydroxide mechanism, with the rate-limiting step being intramolecular proton transfer between the zinc-bound water and His64 through an ordered active-site solvent network; it forms transport metabolons by directly binding (via acidic motif D887ADD) to the C-terminal cytoplasmic tails of the Cl-/HCO3- exchanger AE1 and the Na+/H+ exchanger NHE1 to potentiate their transport activities, and its loss causes the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification, while sulfonamides, coumarins, and diverse anions inhibit the enzyme by zinc-coordinating or non-zinc active-site mechanisms defined by high-resolution crystal structures.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"Carbonic anhydrase II (CA2) is a cytoplasmic zinc metalloenzyme that catalyzes the reversible hydration of CO2 and serves as the dominant cytoplasmic carbonic anhydrase isoform in kidney, eye, and erythroid cells, distinct from membrane-bound CA isoforms that persist in CA II-null tissues [PMID:1431055, PMID:8163345]. CA2 is essential for pH and ion homeostasis in erythroid cells, where its transcriptional repression by v-erbA contributes to the leukemic phenotype [PMID:1354613], and it exhibits cell-type-specific and developmentally regulated expression in the retina [PMID:6430181]. Loss-of-function mutations in CA2 cause autosomal recessive osteopetrosis with mixed renal tubular acidosis (Guibaud–Vainsel syndrome), establishing its non-redundant roles in osteoclast-mediated bone resorption and renal acid–base handling [PMID:12566520].\",\n  \"teleology\": [\n    {\n      \"year\": 1984,\n      \"claim\": \"Establishing where CA II protein resides in vivo: immunohistochemistry revealed cell-type-specific and developmentally regulated CA II expression in the retina (Müller glia in mature chicken, transient expression in embryonic retinoblasts, persistent expression in mouse amacrine neurons), providing the first spatial map of this isoform in neural tissue.\",\n      \"evidence\": \"Polyclonal and monoclonal antibody immunohistochemistry across multiple vertebrate species and developmental stages\",\n      \"pmids\": [\"6430181\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional consequence of CA II in retinal cell types was not tested\",\n        \"Expression data limited to immunohistochemistry without transcript-level confirmation\"\n      ]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Defining CA II as the predominant cytoplasmic carbonic anhydrase in the kidney: CA II-deficient mice lack cytoplasmic CA activity in proximal tubule, thick limb, and collecting duct cells while retaining membrane-associated CA activity, demonstrating that CA II is functionally distinct from membrane-bound isoforms in renal acid–base physiology.\",\n      \"evidence\": \"Immunocytochemistry and cobalt-phosphate histochemical CA assay in CA II-deficient versus control mouse kidneys\",\n      \"pmids\": [\"1431055\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Identity of the residual membrane-bound CA isoform(s) was not determined\",\n        \"Direct measurement of renal acid–base transport defects in the null mice was not performed in this study\"\n      ]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Demonstrating a direct physiological role for CA II in erythroid pH/ion homeostasis: re-expression of CA II in v-erbA-transformed erythroblasts rescued normal sensitivity to pH and ionic strength perturbation, proving that v-erbA-mediated repression of CA2 contributes functionally to the leukemic phenotype.\",\n      \"evidence\": \"Retrovirus-mediated re-expression of CA2 in v-erbA-transformed erythroblasts with phenotypic rescue readout\",\n      \"pmids\": [\"1354613\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Catalytic activity requirement versus scaffolding role was not distinguished\",\n        \"Relevance to human leukemia not directly tested\"\n      ]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Extending the cytoplasmic-versus-membrane CA distinction to ocular tissues: CA II-deficient mice retain membrane-associated CA in ciliary epithelium, corneal endothelium, RPE, Müller cells, and lens, confirming that CA II is the principal cytoplasmic isoform in the eye and that membrane-bound isoforms independently support ocular fluid/ion transport.\",\n      \"evidence\": \"Cobalt-phosphate histochemical CA assay in CA II-deficient versus normal mouse eyes\",\n      \"pmids\": [\"8163345\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific membrane-bound CA isoform identities in ocular tissues were not resolved\",\n        \"Intraocular pressure or fluid transport quantification in null mice was not reported\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing CA2 as the causal gene for Guibaud–Vainsel syndrome: identification of loss-of-function mutations (including a novel frameshift) in consanguineous families with osteopetrosis and mixed renal tubular acidosis proved that CA II is non-redundantly required for osteoclast bone resorption and renal tubular acid secretion in humans.\",\n      \"evidence\": \"Molecular genetic analysis and CA2 sequencing in consanguineous kindreds with measurement of CA II protein levels\",\n      \"pmids\": [\"12566520\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Enzymatic reconstitution of the mutant proteins was not performed\",\n        \"Mechanism by which CA II loss impairs osteoclast function at the molecular level was not defined\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Quantifying inhibitor binding affinity of human CA II: biophysical measurements showed ~2 nM binding of ethoxzolamide with >10°C thermal stabilization, providing a quantitative framework for sulfonamide-based CA II inhibitor pharmacology.\",\n      \"evidence\": \"Displacement ITC and thermal shift assay with purified human CA II protein\",\n      \"pmids\": [\"19582223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Selectivity over other CA isoforms was not compared in this study\",\n        \"In vivo pharmacokinetic relevance of the measured affinity was not addressed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular mechanisms by which cytoplasmic CA II activity is specifically coupled to osteoclast proton secretion and renal tubular acid–base transport remain incompletely defined; whether CA II functions through direct protein–protein interactions with transporters (e.g., bicarbonate exchangers, V-ATPase components) or solely through substrate channeling of H⁺/HCO₃⁻ has not been resolved by the available experimental literature.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural or biochemical evidence for direct CA II–transporter complexes in the timeline\",\n        \"Catalytic versus non-catalytic roles of CA II in cell-type-specific physiology untested\",\n        \"Compensation by other cytoplasmic CA isoforms in CA II-null tissues not systematically assessed\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [2, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"CA2 encodes carbonic anhydrase II, the most catalytically efficient cytoplasmic zinc metalloenzyme among carbonic anhydrase isozymes, catalyzing reversible hydration of CO2 to bicarbonate via a zinc-bound hydroxide mechanism in which intramolecular proton transfer from the zinc-water to His64 through an ordered solvent network constitutes the rate-limiting step [PMID:7574487, PMID:17319692]. The active site zinc is tetrahedrally coordinated by His94, His96, His119, and a water/hydroxide molecule, with Thr199 and Glu106 forming a hydrogen-bond network essential for catalysis [PMID:3151019]. CA2 directly binds the cytoplasmic tails of the Cl⁻/HCO₃⁻ exchanger AE1 (via the D887ADD motif) and the Na⁺/H⁺ exchanger NHE1, forming transport metabolons that potentiate bicarbonate and proton flux across membranes [PMID:9774471, PMID:11606574, PMID:12138085]. Loss-of-function mutations in CA2 cause an autosomal recessive syndrome of osteopetrosis, renal tubular acidosis, and cerebral calcification [PMID:3925334, PMID:12566520].\",\n  \"teleology\": [\n    {\n      \"year\": 1972,\n      \"claim\": \"Determination of the first crystal structure of human CA II revealed the zinc-containing active site and overall protein fold, establishing the structural framework for all subsequent mechanistic studies.\",\n      \"evidence\": \"X-ray crystallography of human carbonic anhydrase C\",\n      \"pmids\": [\"4621826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Resolution insufficient to define hydrogen-bond network or solvent structure\",\n        \"Active-site mechanism and catalytic cycle not yet elucidated\"\n      ]\n    },\n    {\n      \"year\": 1985,\n      \"claim\": \"Demonstration that CA II enzymatic activity and protein are virtually absent in patients with osteopetrosis, renal tubular acidosis, and cerebral calcification established CA2 loss-of-function as the molecular basis of this autosomal recessive syndrome, linking the enzyme to bone resorption and renal acid-base homeostasis.\",\n      \"evidence\": \"HPLC, CO2 hydratase/esterase activity assays, and immunoprecipitation of erythrocyte hemolysates from 18 patients in 11 families\",\n      \"pmids\": [\"3925334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the bone and kidney phenotypes arise from a single common mechanism or separate tissue-specific functions was unclear\",\n        \"Specific causative mutations not yet identified at the DNA level in most families\"\n      ]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"High-resolution refinement of the CA II structure resolved the tetrahedral zinc coordination (His94, His96, His119, water) and the Thr199–Glu106 hydrogen-bond relay, defining the catalytic geometry, while inhibitor co-crystal structures established that sulfonamides coordinate zinc via the sulfonamide nitrogen and that alternative zinc coordination geometries are possible.\",\n      \"evidence\": \"X-ray crystallography at 2.0 Å (apo) and 1.9–3.1 Å (inhibitor complexes)\",\n      \"pmids\": [\"3151019\", \"3151020\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Proton-transfer pathway and rate-limiting step not yet defined\",\n        \"Solvent network in the active site not resolved at this resolution\"\n      ]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Systematic kinetic and mutagenesis studies consolidated the zinc-bound hydroxide mechanism and identified CA II as the most catalytically efficient CA isozyme, framing subsequent work on the proton shuttle.\",\n      \"evidence\": \"Review synthesizing recombinant wild-type and mutant CA kinetics, inhibitor studies, and CA-deficient animal/human data\",\n      \"pmids\": [\"7574487\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Atomic-resolution definition of the proton-transfer solvent bridge remained outstanding\",\n        \"Role of His64 conformational dynamics not directly observed\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Discovery that CA II binds directly to the C-terminal cytoplasmic tail of the Cl⁻/HCO₃⁻ exchanger AE1 with nanomolar affinity introduced the concept that CA II participates in membrane transport by physical association with ion transporters.\",\n      \"evidence\": \"Co-immunoprecipitation from ghost membranes, solid-phase binding assays, affinity chromatography, and immunofluorescence clustering\",\n      \"pmids\": [\"9774471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Functional consequence of the CA II–AE1 interaction on transport activity not yet tested\",\n        \"Binding determinants on AE1 not yet mapped\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapping the CA II binding site on AE1 to the acidic motif D887ADD, with mutagenesis showing that acidic residues are essential, defined the molecular determinants of the CA II–transporter interaction.\",\n      \"evidence\": \"Peptide competition and point-mutant GST-fusion binding assays with immobilized CA II\",\n      \"pmids\": [\"10820026\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structure of the CA II–AE1 peptide complex\",\n        \"Reciprocal mapping of the binding surface on CA II not performed\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Functional demonstration that CA II binding to AE1 potentiates Cl⁻/HCO₃⁻ exchange activity—using CA inhibitors, binding-deficient AE1 mutants, and dominant-negative CA II—established the 'transport metabolon' concept wherein substrate channeling between enzyme and transporter accelerates transmembrane bicarbonate flux.\",\n      \"evidence\": \"Intracellular pH-based anion exchange assay in transfected HEK293 cells with multiple perturbations\",\n      \"pmids\": [\"11606574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether physical tethering alone or catalytic activity at the membrane interface drives the enhancement was not fully resolved\",\n        \"In vivo physiological confirmation in tissue lacking\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Extension of the metabolon concept to NHE1 showed that CA II also binds NHE1's C-terminal region and enhances Na⁺/H⁺ exchange, with phosphorylation of NHE1 greatly increasing CA II binding, revealing a regulated partnership.\",\n      \"evidence\": \"Microtiter plate binding, affinity blotting, co-IP from CHO cells, pH-based transport assays, dominant-negative CA II, phosphorylation studies\",\n      \"pmids\": [\"12138085\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Kinase(s) responsible for the phosphorylation-dependent regulation not identified\",\n        \"Structural basis of phospho-dependent enhancement unknown\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of a novel CA2 frameshift mutation in a family with osteopetrosis plus renal tubular acidosis, alongside the finding that co-inheritance of TCIRG1 and ATP6V1B1 mutations can phenocopy CA II deficiency, mechanistically separated the bone and kidney acid-secretion pathways downstream of CA II.\",\n      \"evidence\": \"Molecular genetic sequencing, homozygosity mapping, and CA II protein quantification in two kindreds\",\n      \"pmids\": [\"12566520\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Small number of families limits generalizability\",\n        \"Relative contribution of CA II to osteoclast versus renal intercalated cell H⁺ secretion not quantified\"\n      ]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"An ultra-high-resolution (1.05 Å) crystal structure combined with molecular dynamics defined the His64 dual conformation and the ordered solvent network mediating proton transfer from zinc-bound water to His64, establishing the rate-limiting proton shuttle as the mechanistic basis for CA II's extraordinary catalytic turnover.\",\n      \"evidence\": \"X-ray crystallography at 1.05 Å with anisotropic B-factor analysis cross-validated by MD simulation\",\n      \"pmids\": [\"17319692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct experimental observation of proton transfer dynamics (e.g., neutron diffraction, time-resolved methods) not yet achieved at that time\",\n        \"Contribution of individual water molecules in the relay not individually tested by mutagenesis\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that coumarins inhibit CA II through a suicide mechanism—hydrolysis to cis-2-hydroxy-cinnamic acid that occludes the active-site entrance without zinc coordination—revealed a fundamentally distinct inhibition mode from classical sulfonamides, expanding the pharmacological toolkit.\",\n      \"evidence\": \"X-ray crystallography of the CA II–coumarin adduct and enzyme kinetics across 13 mammalian CA isoforms\",\n      \"pmids\": [\"19206230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Selectivity profile of coumarins among CA isoforms not fully optimized\",\n        \"In vivo efficacy data for coumarin-class inhibitors limited\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that CA II is upregulated in tumor endothelial cells via VEGF-A/VEGFR signaling and that it promotes survival under lactic acidosis, with acetazolamide reducing metastasis in vivo, extended CA II's physiological role to pH homeostasis in the tumor microenvironment.\",\n      \"evidence\": \"siRNA knockdown, VEGF treatment, xenograft mouse models with acetazolamide, immunohistochemistry\",\n      \"pmids\": [\"31847904\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab study; independent replication needed\",\n        \"Whether the anti-metastatic effect is CA II-specific or reflects pan-CA inhibition by acetazolamide is unresolved\",\n        \"Molecular mechanism linking CA II to endothelial cell survival under acidosis not defined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of the CA II–transporter metabolon (no co-crystal structure of CA II bound to AE1 or NHE1 cytoplasmic domains), the identity of kinases regulating the CA II–NHE1 interaction, direct visualization of proton-transfer dynamics in real time, and whether CA II has non-catalytic scaffolding functions independent of its enzymatic activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No co-crystal structure of the CA II–transporter complex\",\n        \"Kinases phosphorylating NHE1 to enhance CA II binding unidentified\",\n        \"In vivo tissue-specific functions beyond erythrocytes and kidney not systematically characterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 5, 14]},\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [1, 5, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 5, 14]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [6, 7, 8, 9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SLC4A1\",\n      \"SLC9A1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}